Related Experiment Video
Updated: Aug 3, 2025

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing
Published on: July 5, 2019
Preleukemic Fusion Genes Induced via Ionizing Radiation.
Pavol Kosik1, Milan Skorvaga1, Igor Belyaev1
1Department of Radiobiology, Cancer Research Institute, Biomedical Research Center, Slovak Academy of Sciences, 845 05 Bratislava, Slovakia.
Ionizing radiation exposure may increase leukemia risk by causing preleukemic fusion genes (PFGs). These PFGs, however, require secondary mutations in specific stem cells to induce leukemia, explaining their higher incidence in newborns compared to childhood leukemia.
Area of Science:
- Oncology
- Radiation Biology
- Genetics
Background:
- Leukemia incidence is rising, but causative agents remain unclear.
- Ionizing radiation (IR) is a known carcinogen, but IR-induced leukemias are indistinguishable from other types.
- Epidemiological studies link IR exposure to increased leukemia risk.
Purpose of the Study:
- To review the established association between ionizing radiation (IR), preleukemic fusion genes (PFGs), and cancer.
- To focus on recurrent PFGs with a known link to IR exposure.
Main Methods:
- Review of epidemiological data on IR exposure and leukemia.
- Analysis of studies on IR-induced chromosomal translocations and PFGs.
- Examination of the role of PFGs in leukemogenesis.
Main Results:
- IR is known to induce chromosomal translocations, leading to PFGs, considered a "first hit" in leukemia.
- PFGs are found in healthy newborns at much higher rates than childhood leukemia.
- Leukemia development likely requires secondary mutations and specific hematopoietic stem cell populations.
Conclusions:
- PFGs alone are insufficient for leukemia development.
- Secondary mutations and cellular context are critical for IR-induced leukemogenesis.
- Understanding the IR-PFG-cancer link is crucial for risk assessment.
More Related Videos
10:21Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Induced Pluripotent Stem Cells
Somatic...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...